Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 101 related to Buyon: The effect of combined estrogen and progesterone hormone replacement therapy on disease.... (0.12 sec) 

[PDF] The effect of combined estrogen and progesterone hormone replacement therapy on disease …


JP Buyon, MA Petri, MY Kim, KC Kalunian, J … - Ann Intern Med, 2005 - Am Coll Physicians
Background: There is concern that exogenous female hormones may worsen disease
activity in women with systemic lupus ery- thematosus (SLE). Objective: To
evaluate the effect of hormone replacement ther- apy (HRT) on disease ...
Cited by 113 - Related articles - All 4 versions

Combined oral contraceptives in women with systemic lupus erythematosus

- shouxi.net
M Petri, MY Kim, KC Kalunian, J Grossman, BH … - New England Journal of Medicine, 2005 - content.nejm.org
Results The primary end point, a severe lupus flare, occurred in 7 of 91
subjects receiving oral contraceptives (7.7 percent) as compared with 7 of 92
subjects receiving placebo (7.6 percent). The 12-month rates of severe ...
Cited by 111 - Related articles - BL Direct - All 13 versions

A trial of contraceptive methods in women with systemic lupus erythematosus

- ucalgary.ca [PDF] 
J Sanchez-Guerrero, AG Uribe, L Jimenez- … - New England Journal of Medicine, 2005 - content.nejm.org
Methods We conducted a single-blind clinical trial involving 162 women with
systemic lupus erythematosus who were randomly assigned to combined oral
contraceptives, a progestin-only pill, or a copper intrauterine device ...
Cited by 71 - Related articles - BL Direct - All 11 versions

Hormone replacement therapy in systemic lupus erythematosus.


S Kreidstein, MB Urowitz, DD Gladman, J … - The Journal of rheumatology, 1997 - ncbi.nlm.nih.gov
OBJECTIVE: To test whether hormone replacement therapy (HRT) causes an increase
in lupus flares. METHODS: Sixteen postmenopausal patients with systemic lupus
erythematosus (SLE) who had been taking HRT for at least 12 months were ...
Cited by 57 - Related articles - BL Direct - All 2 versions

Classification and definition of major flares in SLE clinical trials.


M Petri, J Buyon, M Kim - Lupus, 1999 - ncbi.nlm.nih.gov
1: Lupus. 1999;8(8):685-91. Classification and definition of major flares
in SLE clinical trials. Petri M, Buyon J, Kim M. Johns ...
Cited by 52 - Related articles - BL Direct - All 3 versions

Menopause hormonal therapy in women with systemic lupus erythematosus


J Sánchez-Guerrero, M González-Pérez, M … - Arthritis and Rheumatism, 2007 - interscience.wiley.com
We conducted a double-blind, randomized clinical trial involving 106 women with
SLE who were in the menopausal transition or in early or late postmenopause.
Patients received a continuous-sequential estrogen-progestogen regimen (n = ...
Cited by 14 - Related articles - BL Direct - All 3 versions

Past use of oral contraceptives and the risk of developing systemic lupus erythematosus


J Sanchez-Guerrero, EW Karlson, MH Liang, … - Arthritis Care & Research - interscience.wiley.com
It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ...
Cited by 114 - Related articles - BL Direct - All 7 versions

Safety of hormone replacement therapy (HRT) in systemic lupus erythematosus (SLE)

- twin-research.com [PDF] 
NK Arden, ME Lloyd, TD Spector, GRV … - Lupus, 1994 - lup.sagepub.com
Despite its obvious benefits, many physicians are reluctant to prescribe HRT to
patients with SLE. ... We have performed a retrospective study in 60
postmenopausal women with SLE including 30 HRT ... Key Words: Systemic ...
Cited by 72 - Related articles - BL Direct - All 6 versions

Disease activity during the premenopausal and postmenopausal periods in women with …


J Sánchez-Guerrero, A Villegas, A Mendoza- … - The American journal of medicine, 2001 - Elsevier
Patients were studied for a mean (± SD) of 6.4 ± 1.7 years (premenopausal, 3.3
± 0.9 years; postmenopausal, 3.2 ± 0.9 years). During the premenopausal
periods, the mean disease activity score was 2.3 ± 2.3 (range, 0 to 9 on a ...
Cited by 20 - Related articles - BL Direct - All 10 versions

Immunizing patients with systemic lupus erythematosus: a review of effectiveness and safety


SG O'Neill, DA Isenberg - Lupus, 2006 - lup.sagepub.com
Concerns regarding the safety and efficacy of immunization in patients with SLE
have persisted for over 60 years, despite the increased risk of infection in
these patients. There are many anecdotal case reports of SLE induction or ...
Cited by 21 - Related articles - BL Direct - All 4 versions


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google